Tripterygium wilfordii Inhibiting Angiogenesis for Rheumatoid Arthritis Treatment
- 1 January 2017
- journal article
- review article
- Published by Elsevier in Journal of the National Medical Association
- Vol. 109 (2) , 142-148
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Brazilin Limits Inflammatory Responses through Induction of Prosurvival Autophagy in Rheumatoid Fibroblast-Like SynoviocytesPLOS ONE, 2015
- Celastrol Inhibits Inflammatory Stimuli-Induced Neutrophil Extracellular Trap FormationCurrent Molecular Medicine, 2015
- Triptolide inhibits osteoclast formation, bone resorption, RANKL-mediated NF-қB activation and titanium particle-induced osteolysis in a mouse modelMolecular and Cellular Endocrinology, 2015
- Extracts ofTripterygium wilfordiiHook F in the Treatment of Rheumatoid Arthritis: A Systemic Review and Meta-Analysis of Randomised Controlled TrialsEvidence-Based Complementary and Alternative Medicine, 2013
- Anti-Angiogenic Effect of Triptolide in Rheumatoid Arthritis by Targeting Angiogenic CascadePLOS ONE, 2013
- Celastrol Inhibits Lipopolysaccharide-Induced Angiogenesis by Suppressing TLR4-Triggered Nuclear Factor-Kappa B ActivationActa Haematologica, 2013
- Therapeutic effects of total alkaloids of Tripterygium wilfordii Hook f. on collagen-induced arthritis in ratsJournal of Ethnopharmacology, 2013
- A Chinese herb Tripterygium wilfordii Hook F in the treatment of rheumatoid arthritis: mechanism, efficacy, and safetyRheumatology International, 2011
- Angiogenesis in rheumatoid arthritisAutoimmunity, 2009
- Triptolide, A Novel Immunosuppressive and Anti-Inflammatory Agent Purified from a Chinese Herb Tripterygium Wilfordii Hook FLeukemia & Lymphoma, 2001